The average price paid by hospitals for cardiac implantable resynchronization pacemakers has dropped 12% over the last year, according to the most recent Modern Healthcare/ECRI Institute Technology ...

MILAN--(BUSINESS WIRE)--Sorin Group (MIL:SRN) (Reuters Code: SORN.MI), a global medical device company and a leader in the treatment of cardiovascular diseases, announced today the launch of REPLY CRT ...

Analysts believe that device makers who are able to launch implantable products whose functioning isn’t hampered by magnetic resonance imaging will win as chronically ill patients are often directed ...

ST. PAUL, Minn.--(BUSINESS WIRE)--St. Jude Medical, Inc. (NYSE:STJ), a global medical device company, today announced approval from the U.S. Food and Drug Administration (FDA) for the Allure Quadra ™ ...

MINNEAPOLIS - Medtronic, Inc. today announced CE (Conformité Européenne) Mark receipt and the European launch of its newest cardiac resynchronization therapy-pacemaker, Viva® CRT-P. The Viva CRT-P is ...

Medtronic announced that it has received FDA approval for its new cardiac resynchronization therapy pacemaker, Viva CRT-P, for patients with HF or atrioventricular block. The device utilizes the ...

Boston Scientific is recalling Ingenio family of pacemakers (includes models Advantio DR EL, Ingenio DR EL, and Vitalio DR EL) and cardiac resynchronization therapy pacemakers (CRT-Ps) due to the risk ...

Most patients with a cardiac resynchronisation therapy (CRT) pacemaker would not benefit from the addition of a defibrillator, according to results from the CeRtiTuDe cohort study presented for the ...

Please provide your email address to receive an email when new articles are posted on . The FDA has approved three quadripolar cardiac resynchronization therapy pacemakers for the treatment of ...

ROCHESTER, NY — Some patients with "normalized" LV function when their primary-prevention defibrillating cardiac-resynchronization-therapy device (CRT-D) nears the end of its service life may safely ...

St. Jude ($STJ) thinks it has built a better pacemaker, an ongoing obsession of the medical device giants in pursuit of defending their market turf. The company has ...

Dublin, Oct. 09, 2019 (GLOBE NEWSWIRE) -- The "Interventional Cardiology: Implantable Pacemaker Products" report has been added to ResearchAndMarkets.com's offering. The global market for implantable ...